All patients were treated with anti-TNFα at the time of TB diagnosis: 42% for IBD, 20% for rheumatoid arthritis, 17% for spondyloarthropathy, 12% for psoriasis. The gene discussed is TNF; the disease is inflammatory bowel disease.